Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Hait WilliamSee Remarks
|
Tax withholdingCommon Stock | 3,133 | $168.85 | $529,007.05 |
DisclosureSEC source: 0001225208-22-002221 · doc4.xml · nonDerivative · entry 2 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,815 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionCommon Stock | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002221 · doc4.xml · nonDerivative · entry 1 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Duato JoaquinDirector · CEO
|
Exercise / conversionRestricted Share Units · Derivative | 5,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002222 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,424 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Duato JoaquinDirector · CEO
|
Tax withholdingCommon Stock | 2,356 | $168.85 | $397,810.60 |
DisclosureSEC source: 0001225208-22-002222 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,165 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Duato JoaquinDirector · CEO
|
Exercise / conversionCommon Stock | 5,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002222 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Gorsky AlexDirector
|
Exercise / conversionRestricted Share Units · Derivative | 11,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002223 · doc4.xml · derivative · entry 5 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,129 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Gorsky AlexDirector
|
Tax withholdingCommon Stock | 4,833 | $168.85 | $816,052.05 |
DisclosureSEC source: 0001225208-22-002223 · doc4.xml · nonDerivative · entry 2 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,954.15 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Gorsky AlexDirector
|
Exercise / conversionCommon Stock | 11,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002223 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,787.15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Gorsky AlexDirector
|
GrantRestricted Share Units · Derivative | 11,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002371 · doc4.xml · derivative · entry 6 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,047 Underlying: Common Stock · 11,047 shares Expires 2032-02-14 F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Gorsky AlexDirector
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 218,215 | $165.89 | $36,199,686.35 |
DisclosureSEC source: 0001225208-22-002371 · doc4.xml · derivative · entry 5 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,215 Underlying: Common Stock · 218,215 shares Expires 2032-02-14 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantRestricted Share Units · Derivative | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002367 · doc4.xml · derivative · entry 6 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,575 Underlying: Common Stock · 2,575 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 50,874 | $165.89 | $8,439,487.86 |
DisclosureSEC source: 0001225208-22-002367 · doc4.xml · derivative · entry 5 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,874 Underlying: Common Stock · 50,874 shares Expires 2032-02-14 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 2,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002368 · doc4.xml · derivative · entry 4 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: Common Stock · 2,190 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 43,256 | $165.89 | $7,175,737.84 |
DisclosureSEC source: 0001225208-22-002368 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,256 Underlying: Common Stock · 43,256 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 5,114 | $165.89 | $848,361.46 |
DisclosureSEC source: 0001225208-22-002368 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,676.0055 F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 11,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002368 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,497.0055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Broadhurst VanessaEVP, Global Corp Aff.
|
GrantRestricted Share Units · Derivative | 1,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002369 · doc4.xml · derivative · entry 4 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Broadhurst VanessaEVP, Global Corp Aff.
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 18,077 | $165.89 | $2,998,793.53 |
DisclosureSEC source: 0001225208-22-002369 · doc4.xml · derivative · entry 3 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,077 Underlying: Common Stock · 18,077 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Duato JoaquinDirector · CEO
|
GrantRestricted Share Units · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002370 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,053 Underlying: Common Stock · 5,053 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Duato JoaquinDirector · CEO
|
Exercise / conversionPerformance Share Units · Derivative | 29,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002370 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,832 Underlying: Common Stock · 29,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. F4 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Duato JoaquinDirector · CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 99,811 | $165.89 | $16,557,646.79 |
DisclosureSEC source: 0001225208-22-002370 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,811 Underlying: Common Stock · 99,811 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Mammen MathaiEVP, Pharm, R&D
|
GrantRestricted Share Units · Derivative | 3,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002372 · doc4.xml · derivative · entry 4 Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,922 Underlying: Common Stock · 3,922 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:00 UTC |
Mammen MathaiEVP, Pharm, R&D
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 38,736 | $165.89 | $6,425,915.04 |
DisclosureSEC source: 0001225208-22-002372 · doc4.xml · derivative · entry 3 Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,736 Underlying: Common Stock · 38,736 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantRestricted Share Units · Derivative | 3,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002373 · doc4.xml · derivative · entry 6 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,347 Underlying: Common Stock · 3,347 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 66,110 | $165.89 | $10,966,987.90 |
DisclosureSEC source: 0001225208-22-002373 · doc4.xml · derivative · entry 5 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,110 Underlying: Common Stock · 66,110 shares Expires 2032-02-14 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 4,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · derivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,014 Underlying: Common Stock · 4,014 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 79,280 | $165.89 | $13,151,759.20 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,280 Underlying: Common Stock · 79,280 shares Expires 2032-02-14 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantRestricted Share Units · Derivative | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002374 · doc4.xml · derivative · entry 6 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530 Underlying: Common Stock · 1,530 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 30,214 | $165.89 | $5,012,200.46 |
DisclosureSEC source: 0001225208-22-002374 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,214 Underlying: Common Stock · 30,214 shares Expires 2032-02-14 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantRestricted Share Units · Derivative | 3,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002376 · doc4.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,131 Underlying: Common Stock · 3,131 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 61,849 | $165.89 | $10,260,130.61 |
DisclosureSEC source: 0001225208-22-002376 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,849 Underlying: Common Stock · 61,849 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantRestricted Share Units · Derivative | 4,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002377 · doc4.xml · derivative · entry 4 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,053 Underlying: Common Stock · 4,053 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 80,055 | $165.89 | $13,280,323.95 |
DisclosureSEC source: 0001225208-22-002377 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,055 Underlying: Common Stock · 80,055 shares Expires 2032-02-14 F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. F3 · date: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Decker Robert JController, CAO
|
GrantRestricted Share Units · Derivative | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002378 · doc4.xml · derivative · entry 6 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 Underlying: Common Stock · 850 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC |
Decker Robert JController, CAO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 8,393 | $165.89 | $1,392,314.77 |
DisclosureSEC source: 0001225208-22-002378 · doc4.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,393 Underlying: Common Stock · 8,393 shares Expires 2032-02-14 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 19, 2022 00:15 UTC |
Hait WilliamSee Remarks
|
GrantRestricted Share Units · Derivative | 3,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002823 · doc4.xml · derivative · entry 4 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,413 Underlying: Common Stock · 3,413 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 19, 2022 00:15 UTC |
Hait WilliamSee Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 33,705 | $165.89 | $5,591,322.45 |
DisclosureSEC source: 0001225208-22-002823 · doc4.xml · derivative · entry 3 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,705 Underlying: Common Stock · 33,705 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 14, 2022 Filed Feb 14, 2023 21:34 UTC |
Swanson James D.See Remarks
|
GrantRestricted Share Units · Derivative | 1,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001899 · doc4.xml · derivative · entry 4 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,961 Underlying: Common Stock · 1,961 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 14, 2023 21:34 UTC |
Swanson James D.See Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 19,368 | $165.89 | $3,212,957.52 |
DisclosureSEC source: 0001225208-23-001899 · doc4.xml · derivative · entry 3 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,368 Underlying: Common Stock · 19,368 shares Expires 2032-02-14 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 01:54 UTC |
Gorsky AlexDirector
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 231,951 | $65.37 Strike: $65.37 | $15,162,636.87 |
DisclosureSEC source: 0001225208-22-000906 · doc4.xml · derivative · entry 7 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 231,951 shares Expires 2022-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 01:54 UTC |
Gorsky AlexDirector
|
Tax withholdingCommon Stock | 150,943 | $167.84 | $25,334,273.12 |
DisclosureSEC source: 0001225208-22-000906 · doc4.xml · nonDerivative · entry 4 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,658.15 F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported herein. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 01:54 UTC |
Gorsky AlexDirector
|
Exercise / conversionCommon Stock | 231,951 | $65.37 | $15,162,636.87 |
DisclosureSEC source: 0001225208-22-000906 · doc4.xml · nonDerivative · entry 3 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 695,601.15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 01:54 UTC |
Duato JoaquinDirector · CEO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 84,423 | $0.00 Strike: $65.37 | $0.00 |
DisclosureSEC source: 0001225208-22-000905 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,423 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 01:54 UTC |
Duato JoaquinDirector · CEO
|
Tax withholdingCommon Stock | 54,378 | $167.84 | $9,126,803.52 |
DisclosureSEC source: 0001225208-22-000905 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,097 F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported herein. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 01:54 UTC |
Duato JoaquinDirector · CEO
|
Exercise / conversionCommon Stock | 84,423 | $65.37 | $5,518,731.51 |
DisclosureSEC source: 0001225208-22-000905 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| December 09, 2021 Filed Jan 20, 2022 01:54 UTC |
Gorsky AlexDirector
|
GiftCommon Stock | 6,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000906 · doc4.xml · nonDerivative · entry 2 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,650.15 Read SEC document |
| December 09, 2021 Filed Jan 20, 2022 01:54 UTC |
Gorsky AlexDirector
|
GiftCommon Stock | 6,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000906 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,970.15 Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:43 UTC |
Decker Robert JController, CAO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-21-014714 · doc4.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,462 Underlying: Common Stock · 5,000 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:43 UTC |
Decker Robert JController, CAO
|
SaleCommon Stock | 5,000 | $163.21 | $816,050.00 |
DisclosureSEC source: 0001225208-21-014714 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,215 Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:43 UTC |
Decker Robert JController, CAO
|
Exercise / conversionCommon Stock | 5,000 | $72.54 | $362,700.00 |
DisclosureSEC source: 0001225208-21-014714 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.